The CDC has reviewed evidence on the safety and efficacy of the herpes zoster vaccine in adults ages 50–59.
Needle-free injector for delivery of Afluria (trivalent, inactivated "split virus" influenza vaccine) in patients aged 18–64 years has been approved.
A retraction has been issued regarding a paper published on a possible link between an H1N1 vaccine and narcolepsy.
Shipping has begun for Afluria (trivalent, inactivated "split virus" influenza vaccine [types A and B]) for the 2014–2015 flu season.
The herpes zoster vaccine is effective in protecting older adults against shingles, even if they later undergo chemotherapy.
New recommendations are presented for meningococcal vaccination in a policy statement published online July 28 in Pediatrics.
Review this clinical resource on 'Influenza Vaccine Comparisons' for fast information when you need it.
With this FREE certified-for-credit activity, review cases including "Vaccines in Childhood; Complex Regional Pain Syndrome".